Additionally, the levels of p-p53, total p53, and total p21 increased, while the levels of cyclin B1, CDK1, and cyclin E1 decreased following ALS and SB202190 treatment compared to the levels in cells treated with ALS alone (Figure 4D and 4E). This evidence concerns the gene CCNB1 and amyotrophic lateral sclerosis.